Table 1. Baseline characteristics of patients with testosterone deficiency syndrome.
| Parameter | TRT group (n=54) | Control group (n=52) | p-value |
|---|---|---|---|
| Age (yr) | 56.7±12.6 | 57.8±11.4 | 0.180 |
| BMI (kg/m2) | 26.2±2.0 | 26.3±3.1 | 0.291 |
| PSA (ng/mL) | 0.8±1.3 | 0.9±1.2 | 0.967 |
| Prostate volume (mL) | 23.8±8.8 | 22.9±7.2 | 0.447 |
| Hemoglobin (g/dL) | 12.7±1.1 | 12.4±1.3 | 0.498 |
| Hematocrit (%) | 36.8±3.4 | 36.6±4.1 | 0.346 |
| Qmax (mL/s) | 14.2±5.6 | 14.1±6.1 | 0.659 |
| PVR (mL) | 14.9±10.6 | 14.6±9.5 | 0.766 |
| Total testosterone (ng/mL) | 2.5±0.6 | 2.6±0.7 | 0.841 |
| IIEF-5 score | 20.7±4.8 | 20.6±4.3 | 0.646 |
| AMS scale | 41.4±9.7 | 39.6±7.4 | 0.361 |
| BDI score | 26.6±4.2 | 27.2±5.3 | 0.272 |
| K-MMSE score | 24.8±4.4 | 23.9±4.6 | 0.395 |
Values are presented as mean±standard deviation.
TRT: testosterone replacement therapy, BMI: body mass index, PSA: prostate-specific antigen, Qmax: maximal urinary flow rate, PVR: postvoid residual volume, IIEF-5: 5-item version of the International Index of Erectile Function questionnaire, AMS: Aging Males' Symptoms, BDI: Beck Depression Inventory, K-MMSE: Korean Mini-Mental State Examination.